| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Somatostatin receptor type 4 |
|---|
| Ligand | BDBM50064029 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | ChEMBL_200515 (CHEMBL801019) |
|---|
| Ki | 3000±n/a nM |
|---|
| Citation |  Hirschmann, R; Hynes, J; Cichy-Knight, MA; van Rijn, RD; Sprengeler, PA; Spoors, PG; Shakespeare, WC; Pietranico-Cole, S; Barbosa, J; Liu, J; Yao, W; Rohrer, S; Smith, AB Modulation of receptor and receptor subtype affinities using diastereomeric and enantiomeric monosaccharide scaffolds as a means to structural and biological diversity. A new route to ether synthesis. J Med Chem41:1382-91 (1998) [PubMed] Article |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Somatostatin receptor type 4 |
|---|
| Name: | Somatostatin receptor type 4 |
|---|
| Synonyms: | SOMATOSTATIN SST4 | SS-4-R | SS4-R | SS4R | SSR4_HUMAN | SST4R | SSTR4 | Somatostatin receptor type 4 (SSTR4) |
|---|
| Type: | Enzyme |
|---|
| Mol. Mass.: | 42015.38 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | P31391 |
|---|
| Residue: | 388 |
|---|
| Sequence: | MSAPSTLPPGGEEGLGTAWPSAANASSAPAEAEEAVAGPGDARAAGMVAIQCIYALVCLV
GLVGNALVIFVILRYAKMKTATNIYLLNLAVADELFMLSVPFVASSAALRHWPFGSVLCR
AVLSVDGLNMFTSVFCLTVLSVDRYVAVVHPLRAATYRRPSVAKLINLGVWLASLLVTLP
IAIFADTRPARGGQAVACNLQWPHPAWSAVFVVYTFLLGFLLPVLAIGLCYLLIVGKMRA
VALRAGWQQRRRSEKKITRLVLMVVVVFVLCWMPFYVVQLLNLFVTSLDATVNHVSLILS
YANSCANPILYGFLSDNFRRFFQRVLCLRCCLLEGAGGAEEEPLDYYATALKSKGGAGCM
CPPLPCQQEALQPEPGRKRIPLTRTTTF
|
|
|
|---|
| BDBM50064029 |
|---|
| n/a |
|---|
| Name | BDBM50064029 |
|---|
| Synonyms: | 5-{(2R,3S,5R,6R)-3-Benzyloxy-5-(1H-imidazol-4-ylmethoxy)-6-[2-(1H-indol-3-yl)-ethoxy]-tetrahydro-pyran-2-ylmethoxy}-pentylamine | CHEMBL28824 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C32H42N4O5 |
|---|
| Mol. Mass. | 562.6997 |
|---|
| SMILES | NCCCCCOC[C@H]1O[C@@H](OCCc2c[nH]c3ccccc23)[C@@H](C[C@@H]1OCc1ccccc1)OCc1cnc[nH]1 |
|---|
| Structure | 
|
|---|
Search and Browse
